AI software developer Gleamer has raised $29.5 million in a Series B funding round.
This latest investment will enable the company to expand its portfolio of solutions, strengthen its European and American teams, and accelerate its international development plans, Gleamer said. To date, Gleamer has raised $39.4 million, which includes a Series A funding round of $8.2 million in 2020 and seed funding of $1.6 million in 2018, the company said.
Gleamer's AI x-ray clinical diagnostic products now serving more than 6,500 users in 650 institutions in 24 countries, with its products processing more than a million medical examinations each month, the company noted.
